Future of CGB, page-23

First 23 Last

Share
Profile

Follow
KenChase

1,067 Posts.

364

13/12/20

07:31

Post #: 49538626
Share

Originally posted by YankieTank: ↑

CGB has/had the Canntab local manufacturing and distribution rights for the Australasian/Asian region.
DFM were meant to fund the upgrade to Biohealths facility so it was capable of manufacturing Canntabs product locally. They now appear to be on their way to being delisted so it seems that manufacturing is a non starter. I suppose the question is the agreement was valid with those two factors in play, is it still valid now that the manufacturing proponent appears void. Perhaps Neil can shed some light on this. The thing with CGB and QBL for that matter is they're good at releasing announcements that appear positive but when things don't eventuate or negative events happen very little is said. I really hope for all holders sake that Canntab is a starter and is adopted by health professionals Australia wide.

Expand

amen, tank, we've been discussing CGB since the QBL days here on HC. I am completely backing what you're saying, definitely what I'm thinking. If some day they price to actually putting in the work whilst seeing results, I'll get back in. but for now, I'm going to wait on the boundary and see how the games unfolding before I place any more hard earned money back to the company. Hope you're well and hope the recent spike has helped you reclaim some losse's. XX Ken our

CGB Price at posting: 1.0¢ Sentiment: Sell Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

PR1

Nanocap Pure Resources acquires Reedy Creek garnet project, WA

PRS

Prospech finds dynamite heavy REE grades from historic core in Finland

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels